• This record comes from PubMed

Pregnancy Outcome in Patients with Common Variable Immunodeficiency

. 2015 Aug ; 35 (6) : 531-7. [epub] 20150818

Language English Country Netherlands Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Links

PubMed 26280892
DOI 10.1007/s10875-015-0188-7
PII: 10.1007/s10875-015-0188-7
Knihovny.cz E-resources

PURPOSE: The aim of our retrospective study was to clarify fertility, pregnancy complications and outcomes in common variable immunodeficiency (CVID) females. METHODS: Retrospective data were obtained from three Czech referral centres. The data were compared with data obtained from the Czech National Registry of Reproduction Health. RESULTS: Our cohort of patients comprised 54 women with 115 pregnancies; 88 pregnancies in 50 females were finished with live births (77 %). In only 8 women (15%) was the diagnosis of CVID established before the first pregnancy. Replacement immunoglobulin therapy was performed in 10 patients without any moderate or severe adverse effects. Compared with the Czech population, the CVID patients suffered significantly more frequently from the threat of preterm labour (p < 0.0001), vaginal bleeding (p = 0.0001), eclampsia/preeclampsia (p = 0.009) and a higher number of stillbirths (p < 0.0001). Furthermore, the frequency of babies with low birth weight (less than 2500 g) born to the CVID patients was increased compared with the normal population (p < 0.0001). Serum IgG, IgA and IgM determination was done in 57 children of 50 mothers showing 13 cases of IgA deficiency (23%). There was no significant difference among the non-symptomatic, symptomatic untreated and symptomatic treated females in any of the determined gynaecological complications. The number of unsuccessful pregnancies was higher in the symptomatic untreated women. CONCLUSIONS: Fertility in CVID patients is not decreased, and their pregnancies could be considered more risky compared with those of the general population.

See more in PubMed

J Clin Immunol. 2007 May;27(3):308-16 PubMed

Br J Obstet Gynaecol. 1993 Dec;100(12):1138-40 PubMed

Lancet. 1966 Nov 26;2(7474):1152-5 PubMed

BMJ Case Rep. 2012 Dec 17;2012:null PubMed

Clin Exp Immunol. 1980 Aug;41(2):303-8 PubMed

Am J Med. 1984 Mar 30;76(3A):73-7 PubMed

Am J Reprod Immunol. 1996 Nov;36(5):248-55 PubMed

Clin Immunol. 1999 Dec;93(3):190-7 PubMed

JAMA. 1982 May 28;247(20):2824-5 PubMed

Eur J Pediatr. 2012 Jan;171(1):121-4 PubMed

Am J Hematol. 1986 Mar;21(3):327-9 PubMed

Arch Gynecol Obstet. 1996;258(3):155-9 PubMed

Nature. 1966 Jun 4;210(5040):1070-1 PubMed

Tohoku J Exp Med. 1986 Aug;149(4):359-65 PubMed

J Clin Immunol. 2001 Mar;21(2):150-4 PubMed

Arch Dis Child. 1973 Aug;48(8):646-8 PubMed

Int Arch Allergy Immunol. 2000 Oct;123(2):177-80 PubMed

Ann Allergy Asthma Immunol. 2012 Jun;108(6):464-5 PubMed

J Lab Clin Med. 1959 Mar;53(3):331-57 PubMed

Am J Hum Genet. 1999 Apr;64(4):1096-109 PubMed

J Clin Immunol. 2015 Feb;35(2):125-34 PubMed

J Clin Invest. 1959 Mar;38(3):579-86 PubMed

Blood. 2012 Feb 16;119(7):1650-7 PubMed

Blut. 1990 Mar;60(3):198-201 PubMed

J Perinatol. 1994 Mar-Apr;14(2):114-7 PubMed

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...